GABBR1

Chr 6AD

gamma-aminobutyric acid type B receptor subunit 1

Also known as: GABABR1, GABBR1-3, GB1, GPRC3A, NEDLC

This gene encodes a receptor for gamma-aminobutyric acid (GABA), which is the main inhibitory neurotransmitter in the mammalian central nervous system. This receptor functions as a heterodimer with GABA(B) receptor 2. Defects in this gene may underlie brain disorders such as schizophrenia and epilepsy. Alternative splicing generates multiple transcript variants, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jan 2016]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.221 OMIM phenotype
Clinical SummaryGABBR1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 140 VUS of 190 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.22LOEUF
pLI 1.000
Z-score 5.98
OE 0.11 (0.060.22)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.82Z-score
OE missense 0.42 (0.380.47)
236 obs / 555.8 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.11 (0.060.22)
00.351.4
Missense OE?0.42 (0.380.47)
00.61.4
Synonymous OE?0.92
01.21.6
LoF obs/exp: 6 / 53.0Missense obs/exp: 236 / 555.8Syn Z: 0.89
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateGABBR1-related neurodevelopmental disorderOTHERAD

This gene — mechanism propensity

DN
0.4983th %ile
GOF
0.6540th %ile
LOF
0.59top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.22
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

190 submitted variants in ClinVar

Classification Summary

Likely Pathogenic8
VUS140
Likely Benign13
Benign3
Conflicting1
8
Likely Pathogenic
140
VUS
13
Likely Benign
3
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
0
8
0
0
8
VUS
16
118
4
2
140
Likely Benign
0
3
1
9
13
Benign
0
0
0
3
3
Conflicting
1
Total16129514165

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

6 pathogenic / likely-pathogenic (of 9) ClinVar copy-number / structural variants overlap GABBR1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

GABBR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →